Global Oral Anti-diabetes Drugs Market Growth (Status and Outlook) 2021-2026
According to this latest study, the 2021 growth of Oral Anti-diabetes Drugs will have significant change from previous year. By the most conservative estimates of global Oral Anti-diabetes Drugs market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2021, from US$ XX million in 2020. Over the next five years the Oral Anti-diabetes Drugs market will register a XX% CAGR in terms of revenue, the global market size will reach US$ XX million by 2026.
This report presents a comprehensive overview, market shares, and growth opportunities of Oral Anti-diabetes Drugs market by product type, application, key players and key regions and countries.
Segmentation by type: breakdown data from 2016 to 2021 in Section 2.3; and forecast to 2026 in section 10.7.
Liquid
Capsule
Tablet
Segmentation by distribution channel: breakdown data from 2016 to 2021, in Section 2.4; and forecast to 2026 in section 10.8.
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the major players in the market. The key players covered in this report: Breakdown data in in Chapter 3.
Sanofi
Eli Lilly
AstraZeneca plc
Astellas Pharma Inc
Johnson & Johnson (Janssen Pharmaceuticals)
Boehringer Ingelheim
Merck
Takeda
Bristol Myers Squibb
Novartis
Pfizer
Abbott
Biocon
Sunpharma
Novo Nordisk
Piramal Healthcare
Bayer Healthcare
Dr. Reddy's Laboratories Ltd
Glenmark Pharmaceuticals Ltd
1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Oral Anti-diabetes Drugs Market Size 2016-2026
2.1.2 Oral Anti-diabetes Drugs Market Size CAGR by Region 2020 VS 2021 VS 2026
2.2 Oral Anti-diabetes Drugs Segment by Type
2.2.1 Liquid
2.2.2 Liquid
2.2.3 Tablet
2.3 Oral Anti-diabetes Drugs Market Size by Type
2.3.1 Global Oral Anti-diabetes Drugs Market Size CAGR by Type
2.3.2 Global Oral Anti-diabetes Drugs Market Size Market Share by Type (2016-2021)
2.4 Oral Anti-diabetes Drugs Segment by Distribution Channel
2.4.1 Hospital Pharmacies
2.4.2 Retail Pharmacies
2.4.3 Online Pharmacies
2.5 Oral Anti-diabetes Drugs Market Size by Distribution Channel
2.5.1 Global Oral Anti-diabetes Drugs Market Size CAGR by Distribution Channel
2.5.2 Global Oral Anti-diabetes Drugs Market Size Market Share by Distribution Channel (2016-2021)
3 Oral Anti-diabetes Drugs Market Size by Players
3.1 Oral Anti-diabetes Drugs Market Size Market Share by Players
3.1.1 Global Oral Anti-diabetes Drugs Revenue by Players (2019-2021E)
3.1.2 Global Oral Anti-diabetes Drugs Revenue Market Share by Players (2019-2021E)
3.2 Global Oral Anti-diabetes Drugs Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) (2019-2021E)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 Oral Anti-diabetes Drugs by Regions
4.1 Oral Anti-diabetes Drugs Market Size by Regions (2016-2021)
4.2 Americas Oral Anti-diabetes Drugs Market Size Growth (2016-2021)
4.3 APAC Oral Anti-diabetes Drugs Market Size Growth (2016-2021)
4.4 Europe Oral Anti-diabetes Drugs Market Size Growth (2016-2021)
4.5 Middle East & Africa Oral Anti-diabetes Drugs Market Size Growth (2016-2021)
5 Americas
5.1 Americas Oral Anti-diabetes Drugs Market Size by Country (2016-2021)
5.2 Americas Oral Anti-diabetes Drugs Market Size by Type (2016-2021)
5.3 Americas Oral Anti-diabetes Drugs Market Size by Distribution Channel (2016-2021)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Oral Anti-diabetes Drugs Market Size by Region (2016-2021)
6.2 APAC Oral Anti-diabetes Drugs Market Size by Type (2016-2021)
6.3 APAC Oral Anti-diabetes Drugs Market Size by Distribution Channel (2016-2021)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 Europe
7.1 Europe Oral Anti-diabetes Drugs by Country (2016-2021)
7.2 Europe Oral Anti-diabetes Drugs Market Size by Type (2016-2021)
7.3 Europe Oral Anti-diabetes Drugs Market Size by Distribution Channel (2016-2021)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Oral Anti-diabetes Drugs by Region (2016-2021)
8.2 Middle East & Africa Oral Anti-diabetes Drugs Market Size by Type (2016-2021)
8.3 Middle East & Africa Oral Anti-diabetes Drugs Market Size by Distribution Channel (2016-2021)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers and Impact
9.1.1 Growing Demand from Key Regions
9.1.2 Growing Demand from Key Applications and Potential Industries
9.2 Market Challenges and Impact
9.3 Market Trends
10 Global Oral Anti-diabetes Drugs Market Forecast
10.1 Global Oral Anti-diabetes Drugs Forecast by Regions (2021-2026)
10.1.1 Global Oral Anti-diabetes Drugs Forecast by Regions (2021-2026)
10.1.2 Americas Oral Anti-diabetes Drugs Forecast
10.1.3 APAC Oral Anti-diabetes Drugs Forecast
10.1.4 Europe Oral Anti-diabetes Drugs Forecast
10.1.5 Middle East & Africa Oral Anti-diabetes Drugs Forecast
10.2 Americas Oral Anti-diabetes Drugs Forecast by Countries (2021-2026)
10.2.1 United States Oral Anti-diabetes Drugs Market Forecast
10.2.2 Canada Oral Anti-diabetes Drugs Market Forecast
10.2.3 Mexico Oral Anti-diabetes Drugs Market Forecast
10.2.4 Brazil Oral Anti-diabetes Drugs Market Forecast
10.3 APAC Oral Anti-diabetes Drugs Forecast by Region (2021-2026)
10.3.1 China Oral Anti-diabetes Drugs Market Forecast
10.3.2 Japan Oral Anti-diabetes Drugs Market Forecast
10.3.3 Korea Oral Anti-diabetes Drugs Market Forecast
10.3.4 Southeast Asia Oral Anti-diabetes Drugs Market Forecast
10.3.5 India Oral Anti-diabetes Drugs Market Forecast
10.3.6 Australia Oral Anti-diabetes Drugs Market Forecast
10.4 Europe Oral Anti-diabetes Drugs Forecast by Country (2021-2026)
10.4.1 Germany Oral Anti-diabetes Drugs Market Forecast
10.4.2 France Oral Anti-diabetes Drugs Market Forecast
10.4.3 UK Oral Anti-diabetes Drugs Market Forecast
10.4.4 Italy Oral Anti-diabetes Drugs Market Forecast
10.4.5 Russia Oral Anti-diabetes Drugs Market Forecast
10.5 Middle East & Africa Oral Anti-diabetes Drugs Forecast by Region (2021-2026)
10.5.1 Egypt Oral Anti-diabetes Drugs Market Forecast
10.5.2 South Africa Oral Anti-diabetes Drugs Market Forecast
10.5.3 Israel Oral Anti-diabetes Drugs Market Forecast
10.5.4 Turkey Oral Anti-diabetes Drugs Market Forecast
10.5.5 GCC Countries Oral Anti-diabetes Drugs Market Forecast
10.6 Global Oral Anti-diabetes Drugs Forecast by Type (2021-2026)
10.7 Global Oral Anti-diabetes Drugs Forecast by Distribution Channel (2021-2026)
11 Key Players Analysis
11.1 Sanofi
11.1.1 Sanofi Company Information
11.1.2 Sanofi Oral Anti-diabetes Drugs Product Offered
11.1.3 Sanofi Oral Anti-diabetes Drugs Revenue, Gross Margin and Market Share (2019-2021)
11.1.4 Sanofi Main Business Overview
11.1.5 Sanofi Latest Developments
11.2 Eli Lilly
11.2.1 Eli Lilly Company Information
11.2.2 Eli Lilly Oral Anti-diabetes Drugs Product Offered
11.2.3 Eli Lilly Oral Anti-diabetes Drugs Revenue, Gross Margin and Market Share (2019-2021)
11.2.4 Eli Lilly Main Business Overview
11.2.5 Eli Lilly Latest Developments
11.3 AstraZeneca plc
11.3.1 AstraZeneca plc Company Information
11.3.2 AstraZeneca plc Oral Anti-diabetes Drugs Product Offered
11.3.3 AstraZeneca plc Oral Anti-diabetes Drugs Revenue, Gross Margin and Market Share (2019-2021)
11.3.4 AstraZeneca plc Main Business Overview
11.3.5 AstraZeneca plc Latest Developments
11.4 Astellas Pharma Inc
11.4.1 Astellas Pharma Inc Company Information
11.4.2 Astellas Pharma Inc Oral Anti-diabetes Drugs Product Offered
11.4.3 Astellas Pharma Inc Oral Anti-diabetes Drugs Revenue, Gross Margin and Market Share (2019-2021)
11.4.4 Astellas Pharma Inc Main Business Overview
11.4.5 Astellas Pharma Inc Latest Developments
11.5 Johnson & Johnson (Janssen Pharmaceuticals)
11.5.1 Johnson & Johnson (Janssen Pharmaceuticals) Company Information
11.5.2 Johnson & Johnson (Janssen Pharmaceuticals) Oral Anti-diabetes Drugs Product Offered
11.5.3 Johnson & Johnson (Janssen Pharmaceuticals) Oral Anti-diabetes Drugs Revenue, Gross Margin and Market Share (2019-2021)
11.5.4 Johnson & Johnson (Janssen Pharmaceuticals) Main Business Overview
11.5.5 Johnson & Johnson (Janssen Pharmaceuticals) Latest Developments
11.6 Boehringer Ingelheim
11.6.1 Boehringer Ingelheim Company Information
11.6.2 Boehringer Ingelheim Oral Anti-diabetes Drugs Product Offered
11.6.3 Boehringer Ingelheim Oral Anti-diabetes Drugs Revenue, Gross Margin and Market Share (2019-2021)
11.6.4 Boehringer Ingelheim Main Business Overview
11.6.5 Boehringer Ingelheim Latest Developments
11.7 Merck
11.7.1 Merck Company Information
11.7.2 Merck Oral Anti-diabetes Drugs Product Offered
11.7.3 Merck Oral Anti-diabetes Drugs Revenue, Gross Margin and Market Share (2019-2021)
11.7.4 Merck Main Business Overview
11.7.5 Merck Latest Developments
11.8 Takeda
11.8.1 Takeda Company Information
11.8.2 Takeda Oral Anti-diabetes Drugs Product Offered
11.8.3 Takeda Oral Anti-diabetes Drugs Revenue, Gross Margin and Market Share (2019-2021)
11.8.4 Takeda Main Business Overview
11.8.5 Takeda Latest Developments
11.9 Bristol Myers Squibb
11.9.1 Bristol Myers Squibb Company Information
11.9.2 Bristol Myers Squibb Oral Anti-diabetes Drugs Product Offered
11.9.3 Bristol Myers Squibb Oral Anti-diabetes Drugs Revenue, Gross Margin and Market Share (2019-2021)
11.9.4 Bristol Myers Squibb Main Business Overview
11.9.5 Bristol Myers Squibb Latest Developments
11.10 Novartis
11.10.1 Novartis Company Information
11.10.2 Novartis Oral Anti-diabetes Drugs Product Offered
11.10.3 Novartis Oral Anti-diabetes Drugs Revenue, Gross Margin and Market Share (2019-2021)
11.10.4 Novartis Main Business Overview
11.10.5 Novartis Latest Developments
11. Pfizer
11.11.1 Pfizer Company Information
11.11.2 Pfizer Oral Anti-diabetes Drugs Product Offered
11.11.3 Pfizer Oral Anti-diabetes Drugs Revenue, Gross Margin and Market Share (2019-2021)
11.11.4 Pfizer Main Business Overview
11.11.5 Pfizer Latest Developments
11.12 Abbott
11.12.1 Abbott Company Information
11.12.2 Abbott Oral Anti-diabetes Drugs Product Offered
11.12.3 Abbott Oral Anti-diabetes Drugs Revenue, Gross Margin and Market Share (2019-2021)
11.12.4 Abbott Main Business Overview
11.12.5 Abbott Latest Developments
11.13 Biocon
11.13.1 Biocon Company Information
11.13.2 Biocon Oral Anti-diabetes Drugs Product Offered
11.13.3 Biocon Oral Anti-diabetes Drugs Revenue, Gross Margin and Market Share (2019-2021)
11.13.4 Biocon Main Business Overview
11.13.5 Biocon Latest Developments
11.14 Sunpharma
11.14.1 Sunpharma Company Information
11.14.2 Sunpharma Oral Anti-diabetes Drugs Product Offered
11.14.3 Sunpharma Oral Anti-diabetes Drugs Revenue, Gross Margin and Market Share (2019-2021)
11.14.4 Sunpharma Main Business Overview
11.14.5 Sunpharma Latest Developments
11.15 Novo Nordisk
11.15.1 Novo Nordisk Company Information
11.15.2 Novo Nordisk Oral Anti-diabetes Drugs Product Offered
11.15.3 Novo Nordisk Oral Anti-diabetes Drugs Revenue, Gross Margin and Market Share (2019-2021)
11.15.4 Novo Nordisk Main Business Overview
11.15.5 Novo Nordisk Latest Developments
11.16 Piramal Healthcare
11.16.1 Piramal Healthcare Company Information
11.16.2 Piramal Healthcare Oral Anti-diabetes Drugs Product Offered
11.16.3 Piramal Healthcare Oral Anti-diabetes Drugs Revenue, Gross Margin and Market Share (2019-2021)
11.16.4 Piramal Healthcare Main Business Overview
11.16.5 Piramal Healthcare Latest Developments
11.17 Bayer Healthcare
11.17.1 Bayer Healthcare Company Information
11.17.2 Bayer Healthcare Oral Anti-diabetes Drugs Product Offered
11.17.3 Bayer Healthcare Oral Anti-diabetes Drugs Revenue, Gross Margin and Market Share (2019-2021)
11.17.4 Bayer Healthcare Main Business Overview
11.17.5 Bayer Healthcare Latest Developments
11.18 Dr. Reddy's Laboratories Ltd
11.18.1 Dr. Reddy's Laboratories Ltd Company Information
11.18.2 Dr. Reddy's Laboratories Ltd Oral Anti-diabetes Drugs Product Offered
11.18.3 Dr. Reddy's Laboratories Ltd Oral Anti-diabetes Drugs Revenue, Gross Margin and Market Share (2019-2021)
11.18.4 Dr. Reddy's Laboratories Ltd Main Business Overview
11.18.5 Dr. Reddy's Laboratories Ltd Latest Developments
11.19 Glenmark Pharmaceuticals Ltd
11.19.1 Glenmark Pharmaceuticals Ltd Company Information
11.19.2 Glenmark Pharmaceuticals Ltd Oral Anti-diabetes Drugs Product Offered
11.19.3 Glenmark Pharmaceuticals Ltd Oral Anti-diabetes Drugs Revenue, Gross Margin and Market Share (2019-2021)
11.19.4 Glenmark Pharmaceuticals Ltd Main Business Overview
11.19.5 Glenmark Pharmaceuticals Ltd Latest Developments
12 Research Findings and Conclusion
Tables and Figures
List of Tables
Table 1. Oral Anti-diabetes Drugs Market Size CAGR by Region (2020-2026) & ($ Millions)
Table 2. Major Players of Liquid
Table 3. Major Players of Capsule
Table 4. Major Players of Tablet
Table 5. Oral Anti-diabetes Drugs Market Size CAGR by Type (2020-2026) & ($ Millions)
Table 6. Global Oral Anti-diabetes Drugs Market Size by Type (2016-2021) & ($ Millions)
Table 7. Global Oral Anti-diabetes Drugs Market Size Market Share by Type (2016-2021)
Table 8. Oral Anti-diabetes Drugs Market Size CAGR by Distribution Channel (2016-2021) & ($ Millions)
Table 9. Global Oral Anti-diabetes Drugs Market Size by Distribution Channel (2016-2021) & ($ Millions)
Table 10. Global Oral Anti-diabetes Drugs Market Size Market Share by Distribution Channel (2016-2021)
Table 11. Global Oral Anti-diabetes Drugs Revenue by Players (2019-2021E) & ($ Millions)
Table 12. Global Oral Anti-diabetes Drugs Revenue Market Share by Players (2019-2021E)
Table 13. Oral Anti-diabetes Drugs Key Players Head office and Products Offered
Table 14. Oral Anti-diabetes Drugs Concentration Ratio (CR3, CR5 and CR10) & (2019-2021E)
Table 15. New Products and Potential Entrants
Table 16. Mergers & Acquisitions, Expansion
Table 17. Global Oral Anti-diabetes Drugs Market Size by Regions 2016-2021 & ($ Millions)
Table 18. Global Oral Anti-diabetes Drugs Market Size Market Share by Regions 2016-2021
Table 19. Americas Oral Anti-diabetes Drugs Market Size by Country (2016-2021) & ($ Millions)
Table 20. Americas Oral Anti-diabetes Drugs Market Size Market Share by Country (2016-2021)
Table 21. Americas Oral Anti-diabetes Drugs Market Size by Type (2016-2021) & ($ Millions)
Table 22. Americas Oral Anti-diabetes Drugs Market Size Market Share by Type (2016-2021)
Table 23. Americas Oral Anti-diabetes Drugs Market Size by Distribution Channel (2016-2021) & ($ Millions)
Table 24. Americas Oral Anti-diabetes Drugs Market Size Market Share by Distribution Channel (2016-2021)
Table 25. APAC Oral Anti-diabetes Drugs Market Size by Region (2016-2021) & ($ Millions)
Table 26. APAC Oral Anti-diabetes Drugs Market Size Market Share by Region (2016-2021)
Table 27. APAC Oral Anti-diabetes Drugs Market Size by Type (2016-2021) & ($ Millions)
Table 28. APAC Oral Anti-diabetes Drugs Market Size Market Share by Type (2016-2021)
Table 29. APAC Oral Anti-diabetes Drugs Market Size by Distribution Channel (2016-2021) & ($ Millions)
Table 30. APAC Oral Anti-diabetes Drugs Market Size Market Share by Distribution Channel (2016-2021)
Table 31. Europe Oral Anti-diabetes Drugs Market Size by Country (2016-2021) & ($ Millions)
Table 32. Europe Oral Anti-diabetes Drugs Market Size Market Share by Country (2016-2021)
Table 33. Europe Oral Anti-diabetes Drugs Market Size by Type (2016-2021) & ($ Millions)
Table 34. Europe Oral Anti-diabetes Drugs Market Size Market Share by Type (2016-2021)
Table 35. Europe Oral Anti-diabetes Drugs Market Size by Distribution Channel (2016-2021) & ($ Millions)
Table 36. Europe Oral Anti-diabetes Drugs Market Size Market Share by Distribution Channel (2016-2021)
Table 37. Middle East & Africa Oral Anti-diabetes Drugs Market Size by Region (2016-2021) & ($ Millions)
Table 38. Middle East & Africa Oral Anti-diabetes Drugs Market Size Market Share by Region (2016-2021)
Table 39. Middle East & Africa Oral Anti-diabetes Drugs Market Size by Type (2016-2021) & ($ Millions)
Table 40. Middle East & Africa Oral Anti-diabetes Drugs Market Size Market Share by Type (2016-2021)
Table 41. Middle East & Africa Oral Anti-diabetes Drugs Market Size by Distribution Channel (2016-2021) & ($ Millions)
Table 42. Middle East & Africa Oral Anti-diabetes Drugs Market Size Market Share by Distribution Channel (2016-2021)
Table 43. Key and Potential Regions of Oral Anti-diabetes Drugs
Table 44. Key Application and Potential Industries of Oral Anti-diabetes Drugs
Table 45. Key Challenges of Oral Anti-diabetes Drugs
Table 46. Key Trends of Oral Anti-diabetes Drugs
Table 47. Global Oral Anti-diabetes Drugs Market Size Forecast by Regions (2021-2026) & ($ Millions)
Table 48. Global Oral Anti-diabetes Drugs Market Size Market Share Forecast by Regions (2021-2026)
Table 49. Global Oral Anti-diabetes Drugs Market Size Forecast by Type (2021-2026) & ($ Millions)
Table 50. Global Oral Anti-diabetes Drugs Market Size Market Share Forecast by Type (2021-2026)
Table 51. Global Oral Anti-diabetes Drugs Market Size Forecast by Distribution Channel (2021-2026) & ($ Millions)
Table 52. Global Oral Anti-diabetes Drugs Market Size Market Share Forecast by Distribution Channel (2021-2026)
Table 53. Sanofi Details, Company Type, Oral Anti-diabetes Drugs Area Served and Its Competitors
Table 54. Sanofi Oral Anti-diabetes Drugs Product Offered
Table 55. Sanofi Oral Anti-diabetes Drugs Revenue ($ million), Gross Margin and Market Share (2019-2021E)
Table 56. Sanofi Main Business
Table 57. Sanofi Latest Developments
Table 58. Eli Lilly Details, Company Type, Oral Anti-diabetes Drugs Area Served and Its Competitors
Table 59. Eli Lilly Oral Anti-diabetes Drugs Product Offered
Table 60. Eli Lilly Main Business
Table 61. Eli Lilly Oral Anti-diabetes Drugs Revenue ($ million), Gross Margin and Market Share (2019-2021E)
Table 62. Eli Lilly Latest Developments
Table 63. AstraZeneca plc Details, Company Type, Oral Anti-diabetes Drugs Area Served and Its Competitors
Table 64. AstraZeneca plc Oral Anti-diabetes Drugs Product Offered
Table 65. AstraZeneca plc Main Business
Table 66. AstraZeneca plc Oral Anti-diabetes Drugs Revenue ($ million), Gross Margin and Market Share (2019-2021E)
Table 67. AstraZeneca plc Latest Developments
Table 68. Astellas Pharma Inc Details, Company Type, Oral Anti-diabetes Drugs Area Served and Its Competitors
Table 69. Astellas Pharma Inc Oral Anti-diabetes Drugs Product Offered
Table 70. Astellas Pharma Inc Main Business
Table 71. Astellas Pharma Inc Oral Anti-diabetes Drugs Revenue ($ million), Gross Margin and Market Share (2019-2021E)
Table 72. Astellas Pharma Inc Latest Developments
Table 73. Johnson & Johnson (Janssen Pharmaceuticals) Details, Company Type, Oral Anti-diabetes Drugs Area Served and Its Competitors
Table 74. Johnson & Johnson (Janssen Pharmaceuticals) Oral Anti-diabetes Drugs Product Offered
Table 75. Johnson & Johnson (Janssen Pharmaceuticals) Main Business
Table 76. Johnson & Johnson (Janssen Pharmaceuticals) Oral Anti-diabetes Drugs Revenue ($ million), Gross Margin and Market Share (2019-2021E)
Table 77. Johnson & Johnson (Janssen Pharmaceuticals) Latest Developments
Table 78. Boehringer Ingelheim Details, Company Type, Oral Anti-diabetes Drugs Area Served and Its Competitors
Table 79. Boehringer Ingelheim Oral Anti-diabetes Drugs Product Offered
Table 80. Boehringer Ingelheim Main Business
Table 81. Boehringer Ingelheim Oral Anti-diabetes Drugs Revenue ($ million), Gross Margin and Market Share (2019-2021E)
Table 82. Boehringer Ingelheim Latest Developments
Table 83. Merck Details, Company Type, Oral Anti-diabetes Drugs Area Served and Its Competitors
Table 84. Merck Oral Anti-diabetes Drugs Product Offered
Table 85. Merck Main Business
Table 86. Merck Oral Anti-diabetes Drugs Revenue ($ million), Gross Margin and Market Share (2019-2021E)
Table 87. Merck Latest Developments
Table 88. Takeda Details, Company Type, Oral Anti-diabetes Drugs Area Served and Its Competitors
Table 89. Takeda Oral Anti-diabetes Drugs Product Offered
Table 90. Takeda Main Business
Table 91. Takeda Oral Anti-diabetes Drugs Revenue ($ million), Gross Margin and Market Share (2019-2021E)
Table 92. Takeda Latest Developments
Table 93. Bristol Myers Squibb Details, Company Type, Oral Anti-diabetes Drugs Area Served and Its Competitors
Table 94. Bristol Myers Squibb Oral Anti-diabetes Drugs Product Offered
Table 95. Bristol Myers Squibb Main Business
Table 96. Bristol Myers Squibb Oral Anti-diabetes Drugs Revenue ($ million), Gross Margin and Market Share (2019-2021E)
Table 97. Bristol Myers Squibb Latest Developments
Table 98. Novartis Details, Company Type, Oral Anti-diabetes Drugs Area Served and Its Competitors
Table 99. Novartis Oral Anti-diabetes Drugs Product Offered
Table 100. Novartis Main Business
Table 101. Novartis Oral Anti-diabetes Drugs Revenue ($ million), Gross Margin and Market Share (2019-2021E)
Table 102. Novartis Latest Developments
Table 103. Pfizer Details, Company Type, Oral Anti-diabetes Drugs Area Served and Its Competitors
Table 104. Pfizer Oral Anti-diabetes Drugs Product Offered
Table 105. Pfizer Oral Anti-diabetes Drugs Revenue ($ million), Gross Margin and Market Share (2019-2021E)
Table 106. Pfizer Main Business
Table 107. Pfizer Latest Developments
Table 108. Abbott Details, Company Type, Oral Anti-diabetes Drugs Area Served and Its Competitors
Table 109. Abbott Oral Anti-diabetes Drugs Product Offered
Table 110. Abbott Main Business
Table 111. Abbott Oral Anti-diabetes Drugs Revenue ($ million), Gross Margin and Market Share (2019-2021E)
Table 112. Abbott Latest Developments
Table 113. Biocon Details, Company Type, Oral Anti-diabetes Drugs Area Served and Its Competitors
Table 114. Biocon Oral Anti-diabetes Drugs Product Offered
Table 115. Biocon Main Business
Table 116. Biocon Oral Anti-diabetes Drugs Revenue ($ million), Gross Margin and Market Share (2019-2021E)
Table 117. Biocon Latest Developments
Table 118. Sunpharma Details, Company Type, Oral Anti-diabetes Drugs Area Served and Its Competitors
Table 119. Sunpharma Oral Anti-diabetes Drugs Product Offered
Table 120. Sunpharma Main Business
Table 121. Sunpharma Oral Anti-diabetes Drugs Revenue ($ million), Gross Margin and Market Share (2019-2021E)
Table 122. Sunpharma Latest Developments
Table 123. Novo Nordisk Details, Company Type, Oral Anti-diabetes Drugs Area Served and Its Competitors
Table 124. Novo Nordisk Oral Anti-diabetes Drugs Product Offered
Table 125. Novo Nordisk Main Business
Table 126. Novo Nordisk Oral Anti-diabetes Drugs Revenue ($ million), Gross Margin and Market Share (2019-2021E)
Table 127. Novo Nordisk Latest Developments
Table 128. Piramal Healthcare Details, Company Type, Oral Anti-diabetes Drugs Area Served and Its Competitors
Table 129. Piramal Healthcare Oral Anti-diabetes Drugs Product Offered
Table 130. Piramal Healthcare Main Business
Table 131. Piramal Healthcare Oral Anti-diabetes Drugs Revenue ($ million), Gross Margin and Market Share (2019-2021E)
Table 132. Piramal Healthcare Latest Developments
Table 133. Bayer Healthcare Details, Company Type, Oral Anti-diabetes Drugs Area Served and Its Competitors
Table 134. Bayer Healthcare Oral Anti-diabetes Drugs Product Offered
Table 135. Bayer Healthcare Main Business
Table 136. Bayer Healthcare Oral Anti-diabetes Drugs Revenue ($ million), Gross Margin and Market Share (2019-2021E)
Table 137. Bayer Healthcare Latest Developments
Table 138. Dr. Reddy's Laboratories Ltd Details, Company Type, Oral Anti-diabetes Drugs Area Served and Its Competitors
Table 139. Dr. Reddy's Laboratories Ltd Oral Anti-diabetes Drugs Product Offered
Table 140. Dr. Reddy's Laboratories Ltd Main Business
Table 141. Dr. Reddy's Laboratories Ltd Oral Anti-diabetes Drugs Revenue ($ million), Gross Margin and Market Share (2019-2021E)
Table 142. Dr. Reddy's Laboratories Ltd Latest Developments
Table 143. Glenmark Pharmaceuticals Ltd Details, Company Type, Oral Anti-diabetes Drugs Area Served and Its Competitors
Table 144. Glenmark Pharmaceuticals Ltd Oral Anti-diabetes Drugs Product Offered
Table 145. Glenmark Pharmaceuticals Ltd Main Business
Table 146. Glenmark Pharmaceuticals Ltd Oral Anti-diabetes Drugs Revenue ($ million), Gross Margin and Market Share (2019-2021E)
Table 147. Glenmark Pharmaceuticals Ltd Latest Developments
List of Figures
Figure 1. Oral Anti-diabetes Drugs Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Oral Anti-diabetes Drugs Market Size Growth Rate 2016-2026 ($ Millions)
Figure 6. Global Oral Anti-diabetes Drugs Market Size Market Share by Type in 2020
Figure 7. Oral Anti-diabetes Drugs in Hospital Pharmacies
Figure 8. Global Oral Anti-diabetes Drugs Market: Hospital Pharmacies (2016-2021) & ($ Millions)
Figure 9. Oral Anti-diabetes Drugs in Retail Pharmacies
Figure 10. Global Oral Anti-diabetes Drugs Market: Retail Pharmacies (2016-2021) & ($ Millions)
Figure 11. Oral Anti-diabetes Drugs in Online Pharmacies
Figure 12. Global Oral Anti-diabetes Drugs Market: Online Pharmacies (2016-2021) & ($ Millions)
Figure 13. Global Oral Anti-diabetes Drugs Market Size Market Share by Distribution Channel in 2020
Figure 14. Global Oral Anti-diabetes Drugs Revenue Market Share by Player in 2020
Figure 15. Global Oral Anti-diabetes Drugs Market Size Market Share by Regions (2016-2021)
Figure 16. Americas Oral Anti-diabetes Drugs Market Size 2016-2021 ($ Millions)
Figure 17. APAC Oral Anti-diabetes Drugs Market Size 2016-2021 ($ Millions)
Figure 18. Europe Oral Anti-diabetes Drugs Market Size 2016-2021 ($ Millions)
Figure 19. Middle East & Africa Oral Anti-diabetes Drugs Market Size 2016-2021 ($ Millions)
Figure 20. Americas Oral Anti-diabetes Drugs Market Size Market Share by Country in 2020
Figure 21. Americas Oral Anti-diabetes Drugs Market Size Market Share by Type in 2020
Figure 22. Americas Oral Anti-diabetes Drugs Market Size Market Share by Distribution Channel in 2020
Figure 23. United States Oral Anti-diabetes Drugs Market Size Growth 2016-2021 ($ Millions)
Figure 24. Canada Oral Anti-diabetes Drugs Market Size Growth 2016-2021 ($ Millions)
Figure 25. Mexico Oral Anti-diabetes Drugs Market Size Growth 2016-2021 ($ Millions)
Figure 26. APAC Oral Anti-diabetes Drugs Market Size Market Share by Regions in 2020
Figure 27. APAC Oral Anti-diabetes Drugs Market Size Market Share by Type in 2020
Figure 28. APAC Oral Anti-diabetes Drugs Market Size Market Share by Distribution Channel in 2020
Figure 29. China Oral Anti-diabetes Drugs Market Size Growth 2016-2021 ($ Millions)
Figure 30. Japan Oral Anti-diabetes Drugs Market Size Growth 2016-2021 ($ Millions)
Figure 31. Korea Oral Anti-diabetes Drugs Market Size Growth 2016-2021 ($ Millions)
Figure 32. Southeast Asia Oral Anti-diabetes Drugs Market Size Growth 2016-2021 ($ Millions)
Figure 33. India Oral Anti-diabetes Drugs Market Size Growth 2016-2021 ($ Millions)
Figure 34. Australia Oral Anti-diabetes Drugs Market Size Growth 2016-2021 ($ Millions)
Figure 35. Europe Oral Anti-diabetes Drugs Market Size Market Share by Country in 2020
Figure 36. Europe Oral Anti-diabetes Drugs Market Size Market Share by Type in 2020
Figure 37. Europe Oral Anti-diabetes Drugs Market Size Market Share by Distribution Channel in 2020
Figure 38. Germany Oral Anti-diabetes Drugs Market Size Growth 2016-2021 ($ Millions)
Figure 39. France Oral Anti-diabetes Drugs Market Size Growth 2016-2021 ($ Millions)
Figure 40. UK Oral Anti-diabetes Drugs Market Size Growth 2016-2021 ($ Millions)
Figure 41. Italy Oral Anti-diabetes Drugs Market Size Growth 2016-2021 ($ Millions)
Figure 42. Russia Oral Anti-diabetes Drugs Market Size Growth 2016-2021 ($ Millions)
Figure 43. Middle East & Africa Oral Anti-diabetes Drugs Market Size Market Share by Region in 2020
Figure 44. Middle East & Africa Oral Anti-diabetes Drugs Market Size Market Share by Type in 2020
Figure 45. Middle East & Africa Oral Anti-diabetes Drugs Market Size Market Share by Distribution Channel in 2020
Figure 46. Egypt Oral Anti-diabetes Drugs Market Size Growth 2016-2021 ($ Millions)
Figure 47. South Africa Oral Anti-diabetes Drugs Market Size Growth 2016-2021 ($ Millions)
Figure 48. Israel Oral Anti-diabetes Drugs Market Size Growth 2016-2021 ($ Millions)
Figure 49. Turkey Oral Anti-diabetes Drugs Market Size Growth 2016-2021 ($ Millions)
Figure 50. GCC Country Oral Anti-diabetes Drugs Market Size Growth 2016-2021 ($ Millions)
Figure 51. Americas Oral Anti-diabetes Drugs Market Size 2021-2026 ($ Millions)
Figure 52. APAC Oral Anti-diabetes Drugs Market Size 2021-2026 ($ Millions)
Figure 53. Europe Oral Anti-diabetes Drugs Market Size 2021-2026 ($ Millions)
Figure 54. Middle East & Africa Oral Anti-diabetes Drugs Market Size 2021-2026 ($ Millions)
Figure 55. United States Oral Anti-diabetes Drugs Market Size 2021-2026 ($ Millions)
Figure 56. Canada Oral Anti-diabetes Drugs Market Size 2021-2026 ($ Millions)
Figure 57. Mexico Oral Anti-diabetes Drugs Market Size 2021-2026 ($ Millions)
Figure 58. Brazil Oral Anti-diabetes Drugs Market Size 2021-2026 ($ Millions)
Figure 59. China Oral Anti-diabetes Drugs Market Size 2021-2026 ($ Millions)
Figure 60. Japan Oral Anti-diabetes Drugs Market Size 2021-2026 ($ Millions)
Figure 61. Korea Oral Anti-diabetes Drugs Market Size 2021-2026 ($ Millions)
Figure 62. Southeast Asia Oral Anti-diabetes Drugs Market Size 2021-2026 ($ Millions)
Figure 63. India Oral Anti-diabetes Drugs Market Size 2021-2026 ($ Millions)
Figure 64. Australia Oral Anti-diabetes Drugs Market Size 2021-2026 ($ Millions)
Figure 65. Germany Oral Anti-diabetes Drugs Market Size 2021-2026 ($ Millions)
Figure 66. France Oral Anti-diabetes Drugs Market Size 2021-2026 ($ Millions)
Figure 67. UK Oral Anti-diabetes Drugs Market Size 2021-2026 ($ Millions)
Figure 68. Italy Oral Anti-diabetes Drugs Market Size 2021-2026 ($ Millions)
Figure 69. Russia Oral Anti-diabetes Drugs Market Size 2021-2026 ($ Millions)
Figure 70. Spain Oral Anti-diabetes Drugs Market Size 2021-2026 ($ Millions)
Figure 71. Egypt Oral Anti-diabetes Drugs Market Size 2021-2026 ($ Millions)
Figure 72. South Africa Oral Anti-diabetes Drugs Market Size 2021-2026 ($ Millions)
Figure 73. Israel Oral Anti-diabetes Drugs Market Size 2021-2026 ($ Millions)
Figure 74. Turkey Oral Anti-diabetes Drugs Market Size 2021-2026 ($ Millions)
Figure 75. GCC Country Oral Anti-diabetes Drugs Market Size 2021-2026 ($ Millions)
Reason to Buy
- Current and future of Machinery & Equipment Market outlook in the developed and emerging markets
- Highlights key business priorities in order to assist companies to realign their business strategies
- The segment that is expected to dominate the Machinery & Equipment Market
- Regions that are expected to witness the fastest growth during the forecast period
- Identify the latest developments, Machinery & Equipment Market shares, and strategies employed by the major market players
- Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the global Machinery & Equipment Market
- Develop/modify business expansion plans by using substantial growth offering developed and emerging markets